DUBENSKY, THOMAS W., JR.,HOSKEN, NANCY A.,ROBBINS, SCOTT H.,MOORE, MARGARET D.
申请号：
CA2873629
公开号：
CA2873629A1
申请日:
2013.05.16
申请国别(地区):
CA
年份:
2013
代理人:
摘要：
Compositions of recombinant HSV-2 proteins and an agonist of the innate immune system, such as an adjuvant, are provided as a vaccine. Proteins include an envelope glycoprotein and a structural protein other than an envelope glycoprotein, e.g., a capsid or tegument protein. The vaccine is for use in either HSV-2 seropositive or seronegative subjects.
